Literature DB >> 17588655

Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection.

Y Ma1, G Krikun, V M Abrahams, G Mor, S Guller.   

Abstract

Placental infection is associated with adverse fetal outcomes. Toll-like receptors (TLRs) are critical regulators of the innate immune response based on their ability to recognize and respond to pathogen-associated molecular patterns expressed by microbes. To date, cell-type specific expression and regulation of TLR function in human term placenta remains largely unelucidated. The goal of the current study was to examine the in vivo and in vitro patterns of TLR expression and function in major cell types of term placenta. Immunohistochemical analysis of terminal and stem villi localized TLR-2, which recognizes peptidoglycan (PG) from Gram-positive bacteria, to endothelial cells and macrophages, and to a lesser extent to syncytiotrophoblast (SCTs) and fibroblasts (FIBs). Staining for TLR-4, the receptor for Gram-negative bacterial lipopolysaccharide (LPS), was most prominent in SCTs and endothelial cells. Results from Western blotting, conventional, and quantitative PCR (qRTPCR) analyses using protein and mRNA isolated from cultures of SCTs and myofibroblasts (mFIBs) revealed that SCTs expressed TLR-2 and TLR-4, whereas mFIBs expressed only TLR-4. In addition, qRTPCR showed that LPS treatment increased TLR-2 expression in SCTs, indicating that infection with Gram-negative bacteria may enhance innate immune responses in placenta toward a broad range of microorganisms. In addition, treatment with LPS increased IL-8 levels in both SCTs and mFIBs, whereas PG treatment only stimulated IL-8 levels in SCTs. Our results indicate that there exist cell type-specific patterns of TLR function in placenta which likely regulate innate immune response at the maternal-fetal interface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588655      PMCID: PMC2064901          DOI: 10.1016/j.placenta.2007.05.003

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  30 in total

1.  A novel immortalized human endometrial stromal cell line with normal progestational response.

Authors:  Graciela Krikun; Gil Mor; Ayesha Alvero; Seth Guller; Frederick Schatz; Eva Sapi; Mizanur Rahman; Rebeca Caze; Mazin Qumsiyeh; Charles J Lockwood
Journal:  Endocrinology       Date:  2004-01-15       Impact factor: 4.736

2.  Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C).

Authors:  Vikki M Abrahams; Todd M Schaefer; John V Fahey; Irene Visintin; Jacqueline A Wright; Paulomi B Aldo; Roberto Romero; Charles R Wira; Gil Mor
Journal:  Hum Reprod       Date:  2006-06-03       Impact factor: 6.918

3.  The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes.

Authors:  Y Lin; H Lee; A H Berg; M P Lisanti; L Shapiro; P E Scherer
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

4.  Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women.

Authors:  M Moussa; P Roques; N Fievet; E Menu; J G Maldonado-Estrada; J Brunerie; R Frydman; X Fritel; F Herve; G Chaouat
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

5.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 6.  Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Jimmy Espinoza
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

7.  Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta.

Authors:  Ulrika Holmlund; Gvido Cebers; Agneta R Dahlfors; Bengt Sandstedt; Katarina Bremme; Eva S Ekström; Annika Scheynius
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

8.  Correlation of in situ detection of infectious agents in the placenta with neonatal outcome.

Authors:  Linda Genen; Gerard J Nuovo; Leonard Krilov; Jonathan M Davis
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

9.  Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis.

Authors:  Kaori Kumazaki; Masahiro Nakayama; Itaru Yanagihara; Noriyuki Suehara; Yoshinao Wada
Journal:  Hum Pathol       Date:  2004-01       Impact factor: 3.466

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  22 in total

Review 1.  Toll-Like Receptors: A Key Marker for Periodontal Disease and Preterm Birth - A Contemporary Review.

Authors:  Prathahini Parthiban; Jaideep Mahendra
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Vitamin C supplementation ameliorates the adverse effects of nicotine on placental hemodynamics and histology in nonhuman primates.

Authors:  Jamie O Lo; Matthias C Schabel; Victoria H J Roberts; Terry K Morgan; Juha P Rasanen; Christopher D Kroenke; Sophie R Shoemaker; Eliot R Spindel; Antonio E Frias
Journal:  Am J Obstet Gynecol       Date:  2015-03       Impact factor: 8.661

3.  The PDE4 inhibitor rolipram prevents NF-kappaB binding activity and proinflammatory cytokine release in human chorionic cells.

Authors:  Roxane Hervé; Thomas Schmitz; Danièle Evain-Brion; Dominique Cabrol; Marie-Josèphe Leroy; Céline Méhats
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

4.  Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Authors:  Seth Guller; Catalin S Buhimschi; Yula Y Ma; Se Te J Huang; Liubin Yang; Edward Kuczynski; Eduardo Zambrano; Charles J Lockwood; Irina A Buhimschi
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

Review 5.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

6.  Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition.

Authors:  Antonio E Frias; Terry K Morgan; Anne E Evans; Juha Rasanen; Karen Y Oh; Kent L Thornburg; Kevin L Grove
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

Review 7.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

Review 8.  Benzopyrene and experimental stressors cause compensatory differentiation in placental trophoblast stem cells.

Authors:  Daniel A Rappolee; Awoniyi O Awonuga; Elizabeth E Puscheck; Sichang Zhou; Yufen Xie
Journal:  Syst Biol Reprod Med       Date:  2010-04       Impact factor: 3.061

Review 9.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

10.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.